Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(18):1377-1382; doi:10.1093/jnci/dji280
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Jönsson, G.
Right arrow Articles by Borg, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jönsson, G.
Right arrow Articles by Borg, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

BRIEF COMMUNICATION

Mapping of a Novel Ocular and Cutaneous Malignant Melanoma Susceptibility Locus to Chromosome 9q21.32

Göran Jönsson, Pär-Ola Bendahl, Therese Sandberg, Azra Kurbasic, Johan Staaf, Lone Sunde, Dorthe G. Crüger, Christian Ingvar, Håkan Olsson, Åke Borg

Affiliations of authors: Department of Oncology, University Hospital, Lund, Sweden (GJ, P-OB, TS, JS, HO, AB); Department of Mathematical Statistics, Lund University, Lund, Sweden (AK); Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark (LS); Department of Clinical Genetics, Vejle County Hospital, Vejle, Denmark (DGC); Department of Surgery, University Hospital, Lund, Sweden (CI); Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund University, Lund, Sweden (AB)

Correspondence to: Åke Borg, PhD, Department of Oncology, Lund University, SE-221 85 Lund, Sweden (e-mail: ake.borg{at}onk.lu.se).

An estimated 10% of all cutaneous malignant melanoma (CMM) cases are inherited, but the genetics of familial CMM are largely unknown. Ocular malignant melanoma (OMM), which is rare, may be associated with familial CMM. We performed a genome-wide scan of two Danish pedigrees with multiple cases of OMM (N = 10) and CMM (N = 3) and other malignancies (with no germline mutations in CDKN2A, CDK4, BRCA1, and BRCA2) to identify melanoma susceptibility genes. Results of parametric linkage analysis are presented as logarithm of the odds (LOD) scores, and all P values are two-sided. Peak two-point parametric LOD score of 2.2 (P = .0007) at D9S167 on chromosome 9q21 was observed. Targeted analysis of a third Danish family with OMM and CMM patients confirmed 9q21 linkage, providing a combined four-point parametric LOD score of 3.02 (nominal P = .00003 and genome-wide P = .086). Two families shared a common haplotype comprising three adjacent and highly polymorphic markers, limiting the region to less than 5 cM and 3 Mbp at 9q21.32. Expression of RASEF, a known gene in this region, was examined in tumor tissue from 10 sporadic CMM lesions and was found to be decreased in 70% of these tumors compared with RASEF expression in a human reference RNA pool from 10 different cell types and in 10 breast tumors.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
W. Maat, S. H. W. Beiboer, M. J. Jager, G. P. M. Luyten, N. A. Gruis, and P. A. van der Velden
Epigenetic Regulation Identifies RASEF as a Tumor-Suppressor Gene in Uveal Melanoma
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1291 - 1298.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. Falchi, T. D. Spector, U. Perks, B. S. Kato, and V. Bataille
Genome-wide search for nevus density shows linkage to two melanoma loci on chromosome 9 and identifies a new QTL on 5q31 in an adult twin cohort
Hum. Mol. Genet., October 15, 2006; 15(20): 2975 - 2979.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.